Business Description
Zhejiang Shapuaisi Pharmaceutical Co Ltd
ISIN : CNE100001TG0
Share Class Description:
SHSE:603168: Class ACompare
Compare
Traded in other countries / regions
603168.China IPO Date
2014-07-02Description
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicine, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.86 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -3.28 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 4.83 | |||||
| Beneish M-Score | -2.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.7 | |||||
| 3-Year EPS without NRI Growth Rate | 75.3 | |||||
| 3-Year Book Growth Rate | 3.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.48 | |||||
| 9-Day RSI | 43.88 | |||||
| 14-Day RSI | 47.59 | |||||
| 6-1 Month Momentum % | 1.96 | |||||
| 12-1 Month Momentum % | -21.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.31 | |||||
| Quick Ratio | 1.04 | |||||
| Cash Ratio | 0.65 | |||||
| Days Inventory | 127.53 | |||||
| Days Sales Outstanding | 26.57 | |||||
| Days Payable | 133.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.27 | |||||
| 3-Year Dividend Growth Rate | 49.8 | |||||
| Forward Dividend Yield % | 0.27 | |||||
| 5-Year Yield-on-Cost % | 0.27 | |||||
| 3-Year Average Share Buyback Ratio | -5.5 | |||||
| Shareholder Yield % | -3.62 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.84 | |||||
| Operating Margin % | -13.97 | |||||
| Net Margin % | -16.77 | |||||
| FCF Margin % | -23.21 | |||||
| ROE % | -4.93 | |||||
| ROA % | -3.97 | |||||
| ROIC % | -4.19 | |||||
| ROC (Joel Greenblatt) % | -9.14 | |||||
| ROCE % | -3.89 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 797.02 | |||||
| Shiller PE Ratio | 46.94 | |||||
| PS Ratio | 5.67 | |||||
| PB Ratio | 1.8 | |||||
| Price-to-Tangible-Book | 2.71 | |||||
| Price-to-Operating-Cash-Flow | 52.58 | |||||
| EV-to-EBIT | -42.98 | |||||
| EV-to-EBITDA | -42.98 | |||||
| EV-to-Revenue | 6.01 | |||||
| EV-to-FCF | -27.55 | |||||
| Price-to-Projected-FCF | 3.95 | |||||
| Price-to-Median-PS-Value | 1.01 | |||||
| Earnings Yield (Greenblatt) % | -2.33 | |||||
| FCF Yield % | -3.87 | |||||
| Forward Rate of Return (Yacktman) % | -31.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Shapuaisi Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 505.579 | ||
| EPS (TTM) (Â¥) | -0.22 | ||
| Beta | 0.79 | ||
| Volatility % | 55.14 | ||
| 14-Day RSI | 47.59 | ||
| 14-Day ATR (Â¥) | 0.4663 | ||
| 20-Day SMA (Â¥) | 8.39 | ||
| 12-1 Month Momentum % | -21.98 | ||
| 52-Week Range (Â¥) | 5.9 - 14.04 | ||
| Shares Outstanding (Mil) | 379.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Shapuaisi Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Shapuaisi Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Shapuaisi Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Shapuaisi Pharmaceutical Co Ltd(SHSE:603168)'s stock price today?
The current price of SHSE:603168 is ¥7.98. The 52 week high of SHSE:603168 is ¥14.04 and 52 week low is ¥5.90.
When is next earnings date of Zhejiang Shapuaisi Pharmaceutical Co Ltd(SHSE:603168)?
The next earnings date of Zhejiang Shapuaisi Pharmaceutical Co Ltd(SHSE:603168) is .
Does Zhejiang Shapuaisi Pharmaceutical Co Ltd(SHSE:603168) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Shapuaisi Pharmaceutical Co Ltd(SHSE:603168) is 0.27% (As of Today), Highest Dividend Payout Ratio of Zhejiang Shapuaisi Pharmaceutical Co Ltd(SHSE:603168) was 0.65. The lowest was 0.27. And the median was 0.4. The  Forward Dividend Yield % of Zhejiang Shapuaisi Pharmaceutical Co Ltd(SHSE:603168) is 0.27%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers